(1)
K HEGAZY, S.; A ELBEDEWY, T.; M SAMI, H. EFFECT OF FENOFIBRATE ADJUVANT THERAPY ON ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR RISK IN EGYPTIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Asian J Pharm Clin Res 2020, 13, 172-179.